Skip Navigation

Display Mode:

  • Choose Default Style
  • Choose High Contrast
California Asthma Care | Controlling Ashtma
  • Asthma Resources Home
  • PAMF Home
  • Site Map
  • Overview
  • Medications
  • Self Care
  • Schools & Daycare Centers
  • Education Resources
  • Asthma Videos
Section TitleMedications
  • Oral Medications
    • Leukotrienes
    • Oral Corticosteroids
    • Theophylline
    Main content

    Leukotriene Modifiers

    Leukotriene modifiers are also called leukotriene receptor antagonists. These medicines are used for long-term control and prevention of asthma symptoms. Leukotrienes are substances made by your body that act as a trigger for an asthma attack. Blocking the action of leukotrienes helps prevent these attacks from occurring. These medicines are taken in pill form once every day.

    Although these medicines may seem like they are having no effect, they work slowly over time to reduce inflammation. Leukotriene modifiers are not as powerful as corticosteroids and don't work effectively in everyone. However, they are generally very safe medicines.

    Examples: Singulair ® (montelukast) and Accolate® (zafirlukast)

    Controller Medications:

    • Prevent asthma symptoms from occurring
    • Can reduce and/or prevent:
      • Inflammation and scarring in the airways
      • Tightening of the muscle bands around the airways (bronchospasm)
    • Do not show immediate results, but work slowly over time
    • Should be taken daily, even when you are not having symptoms
    • Should NOT be used to relieve immediate asthma symptoms
    A Note about Long-Term Controller Medicines in Children

    According to the National Asthma Education and Prevention Program at the National Institutes of Health, long-term controller medicines should be considered when infants or young children have had three or more episodes of wheezing in the previous year and who are at an increased risk of developing asthma because of their own or their parents' history of allergic diseases. They also recommend long-term controller medicines for children who need short-acting bronchodilators (rescue medicines) more than twice a week or have had severe asthma symptoms less than six weeks apart. Without a controller medicine, the underlying inflammation will continue to cause more asthma symptoms.


    Back to top

    • Website Feedback
    • Site Map

    © 2013 Palo Alto Medical Foundation. All rights reserved. Sutter Health is a registered trademark of Sutter Health®, Reg. U.S. Patent. & Trademark office.
    Serving communities around Palo Alto, Mountain View, Fremont, San Jose, San Francisco, Oakland, Dublin, San Mateo & Santa Cruz.